Enovis (ENOV) Cash & Equivalents (2010 - 2026)

Enovis (ENOV) has reported Cash & Equivalents for 17 consecutive years, with $33.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash & Equivalents fell 13.86% year-over-year to $33.1 million; the TTM figure through Apr 2026 stood at $33.1 million (down 13.86% YoY), while the FY2025 annual figure was $36.4 million, down 24.45% from the prior year.
• Cash & Equivalents declined to $33.1 million in Q2 2026 per ENOV's latest filing, from $36.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $661.5 million in Q2 2022 and bottomed at $21.9 million in Q1 2023.
• Historically, Cash & Equivalents has averaged $78.2 million across 5 years, with a median of $36.2 million in 2023.
• Annual changes were most pronounced in 2023 — Cash & Equivalents tumbled 96.69% — and 2024, when it jumped 202.59%.
• Enovis' Cash & Equivalents stood at $24.3 million in 2022, then jumped by 48.96% to $36.2 million in 2023, then jumped by 33.09% to $48.2 million in 2024, then retreated by 24.45% to $36.4 million in 2025, then dropped by 8.96% to $33.1 million in 2026.
• Business Quant data shows ENOV's Cash & Equivalents at $33.1 million in Q2 2026, $36.4 million in Q4 2025, and $33.6 million in Q4 2025.